Heart Failure

Author(s):  
Garrick C. Stewart

Heart failure is a complex clinical syndrome occurring in patients with an abnormality of cardiac structure or function that impairs the ability of the heart to fill with or eject blood. Patients with heart failure develop a constellation of symptoms (dyspnea and fatigue) and signs (edema and rales) that lead to frequent hospitalizations, poor quality of life, and a shortened life expectancy. Heart failure has also been defined as the failure of the heart to pump enough blood to meet the metabolic demands of the body, or the ability to do so only at elevated filling pressures. Congestive heart failure is the end stage for many cardiac diseases. Cardiomyopathy refers to any condition in which there is a structural abnormality of the myocardium itself.

2015 ◽  
Vol 28 (4) ◽  
pp. 851-858 ◽  
Author(s):  
Amanda Braga de Louredo ◽  
Ana Luiza Coelho Leite ◽  
Gisela Rosa Franco Salerno ◽  
Marcelo Fernandes ◽  
Silvana Blascovi-Assis

Abstract Introduction : Heart failure (HF) is a complex clinical syndrome representing the common final pathway of various heart diseases. It is characterized by low exercise tolerance, low survival rates and deteriorated quality of life. Several studies mention Quality of Life (QoL) as an important source of information on how disease truly affects patient's lives. In this context, the assessment of QoL is extremely important to provide data that support the choice of a therapeutic strategy and the assessment of the effectiveness of a treatment. Objectives : This study aimed to investigate and identify the most appropriate and widely used instrument for the assessment of quality of life in patients with HF. Methods : We searched the databases of Lilacs, Medline, Pubmed, Scielo and CAPES to identify relevant articles published in English and Portuguese between 2000 and 2010. Results : We found 25 papers that described, quoted or used instruments for the assessment of QoL in patients with HF. Conclusion : The MLHFQ is the most widely used instrument to assess QoL in patients with HF. Its good metric properties have been confirmed in a large number of studies. In addition, it has a simple structure and is easy to administer, which makes it the most recommended instrument for this purpose.


Author(s):  
Kazem Rahimi

Heart failure is a clinical syndrome characterized by an inadequate cardiac output for the needs of the body in the absence of low filling pressures, and reflects abnormal cardiac structure or function. Although various definitions for acute heart failure (AHF) exist, here AHF is defined as new-onset heart failure or an acute exacerbation of chronic heart failure, requiring urgent therapy. Patients with AHF typically have clinical features of organ hypoperfusion, with or without pulmonary and peripheral oedema.


2014 ◽  
Vol 25 (2) ◽  
pp. 151-162
Author(s):  
Denise Buonocore ◽  
Elizabeth Wallace

Heart failure (HF) is a complex clinical syndrome that results from any structural or functional impairment of ventricular filling or ejection of blood. More than 5.1 million people are living with HF in the United States today. This number will continue to rise with the increase in the aging population. With so many people living with HF, nurses need to be well versed on how best to care for them. The 2013 American College of Cardiology Foundation/American Heart Association guideline for the management of HF is a comprehensive guide for all clinicians caring for patients with HF. The updated guideline was developed to assist providers in decision making in the diagnosis and treatment of HF. The goals of the writing committee were to improve quality of care for patients with HF, optimize their outcomes, and improve the efficient use of various resources in the treatment of patients with HF.


e-CliniC ◽  
2021 ◽  
Vol 9 (1) ◽  
Author(s):  
Nurfadhilah H. Palilati ◽  
Frans E. N. Wantania ◽  
Linda W. A. Rotty

Abstract: Heart failure is a serious health problem and a leading cause of death, illness, and poor quality of life. Although the diagnosis and treatment of this disease has significant progress, the prognosis is still poor. The physical performance of patients with heart failure, for example, measured by a 6-minute walking test can be used to assess the functional capacity and assess the prognosis of the patient. This study was aimed to determine the relationship between physical performance and prognosis of patients with heart failure. This was a literature review study using literatures obtained from three databases, namely Pubmed, Science Direct, and Google Scholar. The keywords used in searching the literatures were "physical performance OR 6 minutes walking test AND heart failure prognosis" and their variations and translations. After the selection, 10 literatures were reviewed. The results showed that any decreases in distance of the 6-minute walking test and in walking speed would increase the risk of rehospitalization and mortality as reported in nine literatures. In conclusion, there was a significant relationship between physical performance and prognosis of patients with heart failure.Keywords: physical performance, prognosis of heart failure Abstrak: Gagal jantung merupakan masalah kesehatan yang serius dan penyebab utama kematian, kesakitan, serta kualitas hidup yang buruk. Meskipun diagnosis dan pengobatan penyakit ini telah mengalami banyak kemajuan namun prognosisnya masih buruk. Performa fisik pasien gagal jantung contohnya diukur dengan tes jalan 6 menit dapat digunakan untuk menilai kapasitas fungsional dan menilai prognosis dari pasien. Penelitian ini bertujuan untuk mengetahui hubungan performa fisik dengan prognosis pasien gagal jantung. Jenis penelitian ialah literature review menggunakan  literatur yang diperoleh dari tiga database yaitu Pubmed, Science Direct. dan Google Scholar. Kata kunci yang digunakan dalam pencarian artikel yaitu “physical performance OR 6 minutes walking test AND heart failure prognosis” dan berbagai variasi serta terjemahan. Hasil seleksi, mendapatkan 10 literature yang dikaji. Hasil penelitian mendapatkan bahwa setiap penurunan jarak yang ditempuh dalam uji jalan 6 menit dan penurunan waktu kecepatan berjalan dapat meningkatkan risiko rehospitalisasi dan kematian yang dilaporkan pada 9 literatur. Simpulan penelitian ini ialah terdapat hubungan bermakna antara performa fisik dengan prognosis pada pasien gagal jantung.Kata kunci: performa fisik, prognosis gagal jantung 


el–Hayah ◽  
2014 ◽  
Vol 4 (2) ◽  
pp. 81 ◽  
Author(s):  
Lailia Nur Rachma

<em>Heart failure is a clinical syndrome characterized by abnormalities in the structure or function of the heart, resulting in inability of heart to pump blood to meet the metabolic needs of the body tissue. Heart failure is characterized by clinical manifestations such as circulation congestion, tightness, fatigue, and weakness. Heart failure is a major problem in industrial and developing Country. Currently, the incidence and prevalence of heart failure tends to increase, it is also accompanied by an increase in mortality of heart failure cases. In the United States, 1 million patients hospitalized due to heart failure cases, which contribute to 50,000 deaths each year. While the number of visits to the hospital due to heart failure estimated at 6.5 million. Heart failure prognosis is generally poor despite the patients accepted adequate therapy. From the data obtained, only about 35% of male patients and 50% female patients who survived after the onset of acute heart failure. Generaly, the data obtained high mortality are occurs in patients with grade IV (presence of symptoms at rest) is about 30-70%, grade III (presence of symptoms with mild activity) 10-20%, class II (presence of symptoms when the activity being 5-10 %). Higher mortality was found in older patients, men, patients with reduced ejection fraction, and in patients with coronary disease. Once someone is suffering from heart failure, then he shall bear the very high cost. In America, the cost of issued for heart failure therapy between 15-40 trillion US$. In this review, we will discuss about pathomechanism of heart failure. So it is expected to be a reference to the diagnosis of patients with heart failure, which is expected to be recognized early on that could ultimately improve the quality of heart failure patient life, and reduce the number of mortality due to heart failure</em>


2018 ◽  
Vol 15 (2) ◽  
pp. 1348
Author(s):  
Gülşah Çamcı ◽  
Sıdıka Oğuz

Millions of people have heart failure around world. Despite the advances in the care, heart failure has a poor prognosis. Palliative care offers patients a care which achieves symptom control with good quality of life. Palliative care is usually identified with cancer patients but individuals with heart failure also need palliative care. According to the World Health Organization, palliative care is needed mostly by patients with cardiovascular conditions followed by cancer patients. Patients with heart failure suffer from several symptoms, they have poor quality of life and it is difficult to estimate the course of their disease. Patients with heart failure, however, do not receive enough palliative care. Patients with heart failure should have palliative care integrated to their care to ensure that they receive palliative care services. The present study investigated palliative care models offered to patients with heart failures, and examined their outcomes. Several studies have found that heart failure patients who receive palliative care had better symptom management and quality of life and reduced hospitalizations.


2019 ◽  
Vol 13 ◽  
pp. 175394471987008 ◽  
Author(s):  
Sophia Giannitsi ◽  
Mara Bougiakli ◽  
Aris Bechlioulis ◽  
Anna Kotsia ◽  
Lampros K. Michalis ◽  
...  

Reduced functional ability and exercise tolerance in patients with heart failure (HF) are associated with poor quality of life and a worse prognosis. The 6-minute walking test (6MWT) is a widely available and well-tolerated test for the assessment of the functional capacity of patients with HF. Although the cardiopulmonary exercise test (a maximal exercise test) remains the gold standard for the evaluation of exercise capacity in patients with HF, the 6MWT (submaximal exercise test) may provide reliable information about the patient’s daily activity. The current review summarizes the value of 6MWT in patients with HF and identifies its usefulness and limitations in everyday clinical practice in populations of HF. We aimed to investigate potential associations of 6MWD with other measures of functional status and determinants of 6MWD in patients with HF as well as to review its prognostic role and changes to various interventions in these patients.


Molecules ◽  
2018 ◽  
Vol 23 (7) ◽  
pp. 1819 ◽  
Author(s):  
Frederic Nduhirabandi ◽  
Gerald Maarman

Heart failure is a multifactorial clinical syndrome characterized by the inability of the heart to pump sufficient blood to the body. Despite recent advances in medical management, poor outcomes in patients with heart failure remain very high. This highlights a need for novel paradigms for effective, preventive and curative strategies. Substantial evidence supports the importance of endogenous melatonin in cardiovascular health and the benefits of melatonin supplementation in various cardiac pathologies and cardiometabolic disorders. Melatonin plays a crucial role in major pathological processes associated with heart failure including ischemic injury, oxidative stress, apoptosis, and cardiac remodeling. In this review, available evidence for the role of melatonin in heart failure is discussed. Current challenges and possible limitations of using melatonin in heart failure are also addressed. While few clinical studies have investigated the role of melatonin in the context of heart failure, current findings from experimental studies support the potential use of melatonin as preventive and adjunctive curative therapy in heart failure.


2002 ◽  
Vol 1 (3) ◽  
pp. 183-188 ◽  
Author(s):  
Debra K Moser

Poor quality of life, social isolation, depression and anxiety all have been linked to increased risk of rehospitalization and mortality in patients with heart failure. Yet, despite evidence of their importance to outcomes in heart failure patients, psychosocial factors are assessed and treated infrequently in clinical practice. Potential reasons for this include: (1) inadequate dissemination of research about the link between psychosocial factors and outcomes; (2) insufficient training in heart–mind interactions that precludes clinicians from taking advantage of what is known; (3) perceived problems with interventions or with the science of heart–mind interactions that interfere with acceptance of what is known; (4) concerns about how to measure psychosocial factors in clinical practice; and (5) lack of curiosity from clinicians about the role of psychosocial factors in their patients. In this article, each of these possible explanations is explored and recommendations suggested.


Sign in / Sign up

Export Citation Format

Share Document